Skip to main content

FDA recall, , Moderate risk

Hologic Brevera Breast Biopsy System Disposable Needle

The Brevera Breast Biopsy System Disposable 9 Gauge Needle contains particulates that can be deposited into breast tissue during use.

What happened

Hologic, Inc., of Marlborough, Massachusetts, recalled the Brevera Breast Biopsy System Disposable 9 Gauge Needle because of the presence of particulates in affected devices that can be deposited into breast tissue during use. The recall involved 681,870 units and was distributed nationwide in the United States.

The company began the recall on December 15, 2025, and the FDA added it to its Enforcement Report on February 6, 2026, when it was also classified.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.

    UDI-DI
    • 1540045512863
    Lot code
    Model No - BREVDISP09; UDI - 1540045512863; All Lots within expiry.

Recall details

Company began the recall
Sold in

US Nationwide distribution.

Company
Hologic, IncMarlborough, Massachusetts
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98172
Recall number
Z-1314-2026
Quantity recalled
681,870 units

All recalls from Hologic, Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)